BSE filing, NSE: CAMLINFINE. Summary written from the filing by ALFA Finder's alert engine.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹81.70
- Market cap
- ₹1,569 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 266.8×Sector 34.1×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
Camlin Fine Sciences Management Change
Mr. Pradip Kanakia ceased to be an Independent Director of Camlin Fine Sciences Ltd effective October 18, 2026, upon completion of his five-year term.
Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences Ltd reported the postal ballot voting results for the appointment of Mr. Atul Pradhan as a Non-Executive Independent Director, confirming the resolution's approval.
Camlin Fine Sciences Employee Stock Options
Camlin Fine Sciences Limited allotted 1,200 equity shares to employees exercising vested stock options under its ESOP 2018 scheme. The issue was priced at Rs. 85.00.
- Value
- ₹0.01 Cr
Camlin Fine Sciences Other Announcement
Camlin Fine Sciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This filing provides periodic data regarding the company's current share ownership structure.
Camlin Fine Sciences Other Announcement
Cyrille Damany, classified as 'Other', sold 1,000,000 equity shares of Camlin Fine Sciences Ltd for Rs. 9.75 Crore. The market sale reduced the holder's stake from 0.65% to 0.13%.
- Value
- ₹9.75 Cr
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.